Reporting Mechanisms for Conflict of Interest Disclosures in Medicine Need Standardization
ASCO officials examined the discrepancies in financial disclosures across platforms and call for a simplified system.
Practice Management
PRACTICE MANAGEMENT
FEATURE ARTICLE
LATEST NEWS
Clinical Practice Guideline Generation During COVID-19
During the COVID-19 pandemic, there will be more of a reliance on expert guidance and less on evidence-based medicine when determining treatment protocols. During the COVID-19 pandemic, there will be more of a reliance on expert guidance and less on evidence-based medicine when determining treatment protocols.
COVID-19 Superinfections and Antimicrobial Resistance
Epidemiologic, clinical, microbiologic and antimicrobial resistance (AMR) data on nosocomial superinfections during the coronavirus disease 2019 (COVID-19) pandemic is needed to inform stewardship.
Phase 3 Trial Assessing Ciclesonide Inhalation Aerosol for COVID-19 Underway
The study will enroll 400 patients with symptomatic coronavirus disease 201.
NIH Trial Investigating Hydroxychloroquine Plus Azithromycin for COVID-19 Begins
The phase 2b trial is expected to include roughly 2000 participants with confirmed SARS-CoV-2 who are experiencing fever, cough, and/or shortness of breath.
Social Distancing Policies Reduced COVID-19 Growth Rate
The impact of four widely adopted social distancing policies reduced the daily growth rate of COVID-19 acrossSS. counties.
Symptomatic COVID-19 Infection Fatality Rate 1.3% in US
The overall infection fatality rate (IFR) among symptomatic COVID-19 cases (IFR-S) in the United States is estimated at 1.3%.
Meta-Analysis Links Smoking to COVID-19 Disease Progression
Smokers have an increased likelihood of COVID-19 disease progression.
Disparities Identified in Risk of COVID-19 Among Race, Household Income
Researchers sought to identify disparities in risk to prevent, identify, and treat COVID-19-related severe illness and limit diverging outcomes for vulnerable subgroups.
COVID-19 Pandemic Slowing Cancer Research
Nearly half of cancer research has been stopped due to the COVID-19 pandemic.
Serving the Underserved via Teledermatology During COVID-19
The pandemic, and lifted restrictions in telehealth delivery, are hastening the adoption teledermatology in underserved patient populations.
Want to read more?
Please login or register first to view this content.
Next post in Practice Management
